Questions about Bipolar Disorder
Can changes in gut bacteria help manage symptoms of bipolar disorder and depression?
Early research shows gut bacteria differ in people with bipolar disorder and depression, but it's too soon to say whether changing gut bacteria can manage symptoms.
Full answer →Are there lower levels of GDNF in the blood of people with bipolar disorder?
Research suggests GDNF levels may be lower in people with bipolar disorder, especially during manic episodes, but findings are mixed and not definitive.
Full answer →What does the research say about psychosis rates in people with bipolar disorder?
A large meta-analysis found that about 47% of people with bipolar disorder experience mood-incongruent psychosis, and psychotic symptoms are common, especially in bipolar I disorder.
Full answer →All Bipolar Disorder Articles
- Meta-analysis reveals shorter telomeres in bipolar disorder versus healthy control populations across large sample sizes
- Bipolar disorder is associated with a 3.65-fold higher risk of Parkinson's disease in six cohort studies
- Cocaine use disorder prevalence in bipolar disorder is 10.94 percent with worse clinical outcomes
- Diffusion tensor imaging shows lower fractional anisotropy in bipolar disorder white matter tracts
- GLP-1RAs reduce weight and HbA1c in severe mental illness with low discontinuation rates
- Meta-analysis finds decreased GDNF levels in bipolar disorder but high heterogeneity limits conclusions
- Meta-analysis reviews psychosis prevalence in bipolar disorder patients across 285 studies
- Observational study identifies sensory perception differences in schizophrenia and first-episode psychosis
- Narrative review explores microbiome mechanisms as a promising adjunctive avenue for managing depression, anxiety, bipolar disorder, and schizophrenia
- Parental severe mental illness associated with reduced offspring cognitive and academic performance in large meta-analysis
- Blood biomarker variance in UK Biobank influenced by technical, demographic, and behavioral factors
- Narrative review examines multidisciplinary strategies for metabolic syndrome in bipolar disorder
- Multi-omics data integration in Spanish psychiatric patients and controls
- Mendelian randomization suggests loneliness causally increases schizophrenia and major depressive disorder risk
- Cross-trait analyses reveal complex genetic overlaps between cortical morphology and psychiatric disorders
- Meta-analysis finds gamma neuromodulation benefits in schizophrenia and major depressive disorder
- Plasma NfL levels elevated in bipolar and depressive disorders in UK Biobank cohort
- FDA Approves Lamotrigine Tablets (lamotrigine) for Epilepsy and Bipolar Disorder Maintenance
- Mental health syndemics reduce ART adherence and impair viral suppression in people living with HIV
- Hypoxia-cognition training showed no significant effects on prefrontal or hippocampal microstructure in remitted mood disorder patients
- Social risk factors show larger effect sizes than polygenic risk scores for bipolar disorder in cohort study
- Protocol outlines target trial emulation for bipolar disorder treatments in patients with opioid use disorder
- FDA Approves Lamotrigine for Adjunctive Therapy in Epilepsy and Maintenance in Bipolar I Disorder
- FDA Approves Depakote ER (divalproex sodium) for Acute Manic or Mixed Episodes in Bipolar Disorder
- FDA Approves Depakote (divalproex sodium) for Manic Episodes Associated with Bipolar Disorder
- Meta-analysis identifies distinct and shared amygdala connectivity patterns in major depression and bipolar disorder
- Transcriptomic meta-analysis in bipolar disorder identifies mitochondrial, synaptic, and inflammatory pathway genes
- Insomnia's association with cognitive function studied in 170 bipolar disorder outpatients